Producer
Meggle Pharma
German dairy and pharmaceutical excipient company. Through its InhaLac product line, one of two dominant global suppliers of inhalation-grade lactose monohydrate for DPI formulations. Inhalation lactose is a high-value niche — technically demanding particle size engineering from dairy lactose.
1
Inputs supplied
1
Goods downstream
1
Facilities
0
Stories
What they make
1 input Meggle Pharma supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Meggle Pharma makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
InhaLac (Inhalation-Grade Lactose) — World #1
30%Oral Solid Dose Pharmaceutical Excipients
25%Dairy Ingredients & Food (MEGGLE parent)
45%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2023
Alpha-lactose monohydrate from MEGGLE's Wasserburg dairy flows into two completely unrelated supply chains depending on particle size engineering: (1) Food and tablet excipient — commodity lactose for infant formula, confectionery, and OTC tablet manufacturing; the same substance that makes baby formula sweet and binds Tylenol tablets; (2) DPI respiratory medicine carrier — InhaLac inhalation-grade lactose with tightly controlled particle size distribution becomes the carrier for dry powder asthma, COPD, and respiratory biologics drugs. Patients inhaling a DPI like Advair Diskus or Spiriva breathe in drug particles adhered to InhaLac lactose surfaces; the lactose deposits in the mouth/throat while the drug micronizes into the lung. MEGGLE's two lactose markets — food ingredient and DPI pharmaceutical — are derived from the same milk, the same cheese making process, and the same Bavarian facility. A disruption at MEGGLE's Wasserburg lactose plant would simultaneously affect dairy ingredient supply for infant formula (food supply chain) and the carrier excipient for dry powder inhalers used by 100+ million asthma and COPD patients globally (healthcare supply chain).
MEGGLE GmbH & Co. KG ↗Origin2023
MEGGLE was founded in 1887 in Wasserburg am Inn, Bavaria — a Bavarian cheese and dairy company operating continuously from the same site for 137 years. Lactose is a byproduct of cheese making: when rennet curds milk into cheese curds, the liquid whey remaining contains approximately 4-5% lactose. MEGGLE's dairy operations generate whey in large volumes; the company developed pharmaceutical-grade lactose processing as a value-added application for what would otherwise be a lower-value dairy stream. Inhalation-grade lactose (InhaLac) is the highest-value lactose application: pharmaceutical-grade milling and air classification to precise particle size specifications commands EUR 20-50/kg vs. EUR 1-3/kg for commodity food lactose. MEGGLE's pharmaceutical excipient business emerged from a 1887 Bavarian cheese dairy's accumulated expertise in lactose crystallization and purification. A Bavarian cheese company that has been making dairy products since 1887 is now one of two dominant global suppliers of the carrier particle in dry powder asthma inhalers.
MEGGLE GmbH & Co. KG ↗